Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by Benedict16thon May 21, 2020 2:12pm
74 Views
Post# 31057298

RE:RE:RE:Hall of Fame - Goodman

RE:RE:RE:Hall of Fame - GoodmanMug, please I am no dummy, do not put words in my mouth or take me out of context, I do not feel cheated but I made a decision and admit to have made an error in believing and or assuming that GUD MNGT  would repeat what they had done with Paladin. Further way back than 6 Yrs, They did imply that with GUD he would accelerate success much faster than Paladin because of the funds $$ GUD  raised with they did not have at Paladin. Only later on they started to sing that theh investment  was for grand kids.  Yes, I was wrong with six Years of waste of time and I blame myself for being gullible. Yes, GUD MNGT failed because the biotech sectors offered huge opportunities in M&A. in the last 6 Yrs in frontier area such genetics and Kart. GUD invested in funds of funds that produced nothing for GUD shareholder to show for in terms of great new frontiers drugs. Who failed?
MUG, just tell me with respect, if GUD MNGT strongly feel to have been so very successful with GUD though "the market does not think so" why than on heaven and hell do they feel they need to keep talking and talking about Paladin past success?  Rather, why do they not show and talk about the success of GUD share price? That is what the market cares about.  GUD MNGT had to use share buyback to support GUD. Is this a growth strategy.  CEO and MNGT are rewarded for present and future success and or asked to move on for failure.
Bullboard Posts